IP Library Granted Patent US 8,226,981
Granted Patent B2
US 8,226,981 · App. 11/896,753 · Granted Jul 24, 2012

Method of preparing a taste-masking oral dosage form

Assignee: Medical and Pharmaceutical Industry Technology and Development Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,226,981
App. No.
11/896,753
Granted
Jul 24, 2012
Kind
B2
Abstract

A method of preparing a taste-masking oral dosage form is provided. The method includes providing a first solution comprising a pharmaceutically active ingredient and a starch, providing a second solution comprising a hydrophilic polymer and a surfactant, blending the first and second solution to form a plurality of microparticles by a granulating process, wherein the microparticle is a co-crystal structure comprising the pharmaceutically active ingredient and the starch, and performing a compression-molding process to form the tablet.

Claims (24)

1. A method of preparing a taste-masking oral dosage form, comprising:

a. providing a first solution comprising a pharmaceutically active ingredient and a starch;

b. heating said first solution to about 90° C. to dissolve the pharmaceutically active ingredient and the starch;

c. providing a second solution comprising a hydrophilic polymer and a surfactant;

d. blending the first and second solutions with continuous stirring to drop the temperature to lower than room temperature;

e. precipitating out crystalline microparticles comprising the pharmaceutically active ingredient and the starch, wherein the diameter of said crystalline particles is about 150 to about 360 microns; and

f. compressing said crystalline microparticles into a tablet having a porosity of about 30% to about 70% and a brittleness of less than 2%.

2. The method as claimed in claim 1 , wherein the starch comprises amylodextrin, hydroxyethyl starch, hydropropyl starch, carboxymethyl starch, acetylated starch, or phosphorylated starch.

3. The method as claimed in claim 1 , wherein the hydrophilic polymer comprises polyethylene glycol (PEG), polyvinyl pyrrolidone (PVP), carbopol, polysaccharide, agar, methyl cellulose (MC), or hydroxypropyl methyl cellulose (HPMC).

4. The method as claimed in claim 1 , wherein the surfactant comprises an edible surfactant.

5. The method as claimed in claim 1 , wherein the surfactant comprises lecithin.

6. The method as claimed in claim 1 , after the first solution is added into the second solution and blended, an excipient further comprising adding excipients into the blended solution.

7. The method as claimed in claim 6 , wherein the excipient comprises disintegrating agents, effervescent, lubricants, or sweeteners.

8. The method as claimed in claim 6 , wherein the excipient comprises saccharide, alcohol, or sugar alcohol.

9. The method as claimed in claim 8 , wherein saccharide comprises monosaccharide or disaccharide.

10. The method as claimed in claim 8 , wherein sugar alcohol comprises mannitol, sorbitol, xylitol, or glycerol.

11. The method as claimed in claim 1 , wherein a molding pressure of the compression-molding is about 800 lb/cm 2 to about.1200 lb/cm 2 .

12. The method as claimed in claim 1 , wherein a molding speed of the compression-molding is about 15 rpm to bout 20 rpm.

13. The method as claimed in claim 1 , wherein the pharmaceutically active ingredient in a proportion is about 35% to about 45% by weight of the entire tablet.

14. The method as claimed in claim 1 , wherein the starch is about 20% to about 30% by weight of the entire tablet.

15. The method as claimed in claim 1 , wherein the hydrophilic polymer is about 2% to about 10% by weight of the entire tablet.

16. The method as claimed in claim 1 , wherein the surfactant is about 2% to about 10% by weight of the entire tablet.

17. The method as claimed in claim 6 , wherein the excipient is about 40% to about 50% by weight of the entire tablet.

18. The method as claimed in claim 1 , wherein the solvent of the first solution is water.

Assignments (2)
CHANGE OF NAME Recorded Sep 21, 2010
From: PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
To: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
Reel/Frame 025017/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2007
From: YANG, CHIH-CHIANG; WANG, WEN-CHE; CHEN, HUI-YU
To: PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
Reel/Frame 019839/0151 →
Priority Claims (1)
TW 93104745 A · Feb 25, 2004 · national
Continuity (2)
Division 10839243 · May 6, 2004
Related Publication 20080003297A1 · Jan 3, 2008